Schiff Collusion with Whistleblower the Last Straw By

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
88
Schiff Collusion with Whistleblower the Last Straw
By Daniel John Sobieski < >

Perhaps House Intelligence Committee chairman Rep. Adam Schiff (D-Calif.), would like to produce a transcript of his secret meeting with Fusion GPS founder Glenn Simpson at the Aspen Security Forum in July 2018. Or maybe someone like ranking member Devin Nunes (R-Calif.) can make up a "parody" and read it into the record, as Schiff did with President Trump's call with Ukrainian president Volodymyr Zelensky, both of whom publicly denied any collusion, pressure, or quid pro quo.

Liar and leaker Schiff had a transcript of the call and still made up his fable rivaling his fairy tale about having mounds of available evidence for everyone to see abut Trump's mythical collusion with Russia. We don't have a transcript of Schiff's meeting with Simpson, so we should be even freer to make stuff up about what each said, what each meant and heard, and what quid was promised for which quo.

Like Schiff's Russian collusion delusion, Ukrainegate, to coin a phrase, is a made up scandal involving a questionable document with unverifiable or incorrect statements and allegations, chock-full of made up stuff and hearsay. Like the Steele dossier produced through Fusion GPS, the Ukraine "whistleblower's" letter to the inspector general is largely unverifiable hearsay or outright fiction. Written by a CIA mole assigned to the White House who was not in the room or on the call, it is designed for one purpose: to bring down a sitting and duly elected president.

Now we find that Adam Schiff and committee staff had a copy of the letters before it was submitted to the I.G. On Wednesday, the New York Times published a report that Schiff "learned about the outlines of a C.I.A. officer's concerns that President Trump had abused his power days before the officer filed a whistle-blower complaint." As the New York Times related:

The early account by the future whistle-blower shows how determined he was to make known his allegations that Mr. Trump asked Ukraine's government to interfere on his behalf in the 2020 election. It also explains how Mr. Schiff knew to press for the complaint when the Trump administration initially blocked lawmakers from seeing it. ...

Before going to Congress, the C.I.A. officer had a colleague convey his accusations to the agency's top lawyer. Concerned about how that avenue for airing his allegations was unfolding, the officer then approached a House Intelligence Committee aide, alerting him to the accusation against Mr. Trump. In both cases, the original accusation was vague.

The House staff member, following the committee's procedures, suggested the officer find a lawyer to advise him and file a whistle-blower complaint. The aide shared some of what the officer conveyed to Mr. Schiff.

Schiff and his staff claim they had no hand in writing or editing the letter and did not coach the so-called whistleblower, even though his letter reads more like a legal brief written by a committee of lawyers. Schiff, with his track record, is not to be believed.

Take Schiff's meeting with Simpson, an exercise in hypocrisy if nothing else. Schiff, it may be remembered, accused House Intelligence Committee chair Devin Nunes of conspiracy with President Trump. Conspiracies against President Trump and conspiring with Deep-State players are okay in Schiff's alternate universe. As Chuck Ross writes in the Daily Caller:

The Schiff-Simpson meeting has come under scrutiny because of Simpson's role in pushing the unverified Trump-Russia collusion conspiracy theory. Simpson has also been accused by some Republican lawmakers of lying to the House Intelligence Committee about his interactions with government officials while working on the dossier.

During testimony to the House panel on Nov. 14, 2017, Simpson withheld that he met with Justice Department official Bruce Ohr prior to the November 2016 election. Simpson said that he met Ohr only after the election. But Ohr told Congress on Aug. 28, 2018 that he and Simpson met on Aug. 22, 2016 at Simpson's request. They met again on Dec. 10, 2016.

Ohr's wife worked as a contractor for Fusion during the 2016 campaign. And after the election, Ohr served as the back channel between the FBI and Christopher Steele, the former British spy who worked for Fusion GPS on the dossier project.

During the same testimony in which Simpson has been accused of lying, Schiff sought investigative leads from the Fusion GPS founder.

Schiff, who once called the rooftop heroes of Benghazi liars, is at it again. He is not uncovering corruption; he is part of it. His is the corruption that needs to be exposed, and his Intelligence Committee is part of the swamp that needs to be drained.

Count Schiff among the many leakers who have released classified information and testimony designed to damage and slander the Trump administration. During the testimony of Donald Trump, Jr. before the House Intelligence Committee, Rep. Schiff repeatedly left the room. Coincidentally, of course, leaked information from that testimony began appearing in anti-Trump media even before the testimony concluded:

Donald Trump Jr. and his lawyer formally requested an investigation Tuesday into leaks from the House Intelligence Committee that followed Trump's participation in a closed-door interview with committee members and staffers last week.

"The public release of confidential non-public information by Committee members continued unabated" for 24 hours after Trump's supposedly confidential interview last week, Trump's lawyer, Alan Futerfas, wrote in a letter delivered Tuesday afternoon.

The four-page letter, addressed to Rep. K. Michael Conaway (R-Tex.), the panel chairman overseeing the Russia investigation, complains about public comments made by three members of the panel, all Democrats, including the highest-ranking minority member of the panel, Rep. Adam B. Schiff (D-Calif.). The letter says that members and staffers began "selectively leaking information" even before the closed-door meeting ended.

Schiff sent a House intel staffer on a trip to Ukraine during August 24–31, just 12 days after receiving the whistleblower complaint. To do what? To dig up what? It is reported the staffer met with the previous president of Ukraine, a friend of President Obama's.

As reported by Gateway Pundit, Adam Schiff has strong ties to a prominent Ukrainian arms-dealer, Igor Pasternak, who has organized fundraisers for Schiff:

In 2013 Ukrainian Igor Pasternak held two different fund raisers for Schiff asking for contributions between $1,000 and $2,500[.] ... Pasternak was reportedly in and around the Ukraine at the same time that Vice President Joe Biden had his son appointed to the Board of the Ukraine's largest oil and gas producer[.]

Let's investigate collusion with Ukraine to affect U.S. elections, Rep. Schiff. Yours.

Schiff has defended Hillary Clinton and lied about her involvement in Uranium One and giving Russia 20 percent of our uranium reserves. Talk about collusion with Russia!

Adam Schiff is a political hack, a swamp creature slithering past the truth while saying the American people can't handle the truth. What they can't handle is swamp things like Adam Schiff. It is he who should be impeached and removed from office
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 5

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 1

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Thor Equities Sells Amazon Distribution Center for $157M

Updated Category News Views 191

Thor Equities Group Successfully Transacts Major Sale Thor Equities Group, recognized as a leader in urban real estate development and management, has successfully concluded the sale of a significant industrial property. The property, located at 280 Richards Street in Brooklyn, was sold for an impressive $157 million. Details of the 280 Richards Street Property This...

Continue Reading
Exploring the Dynamics of Cloud Object Storage Growth and Demand

Updated Category News Views 169

Understanding Cloud Object Storage Market Evolution The growth of the Cloud Object Storage Market is driven by the exponential rise in unstructured data, increasing adoption of cloud-based services, and the need for scalable, cost-effective storage solutions across industries. Enterprises are rapidly shifting toward hybrid and multi-cloud strategies, boosting demand for...

Continue Reading
Danone's Strategic Acquisition of Kate Farms to Drive Growth

Updated Category News Views 341

Danone Strengthens U.S. Nutrition Offerings with Kate Farms Purchase In a significant move for its health-focused division, Danone has officially finalized the acquisition of a majority stake in Kate Farms. This acquisition positions Danone as a key player in the specialized nutrition market by integrating Kate Farms’ lineup of plant-based, organic nutrition products....

Continue Reading
GSK plc Faces Class Action Over Zantac and Investor Rights

Updated Category News Views 175

Rosen Law Firm Encourages GSK plc Investors to Take Action Rosen Law Firm, renowned for advocating investor rights, is reaching out to shareholders of GSK plc (NYSE: GSK). The firm has been alerted to a class action alleging that GSK misrepresented crucial information regarding its business operations during the class period from February 5, 2020, to August 14, 2022....

Continue Reading
Alibaba's Recent Stock Surge Driven by Cloud Innovation

Updated Category News Views 181

Alibaba Group Holding Ltd's Stock Performance Alibaba Group Holding Ltd (NASDAQ: BABA) recently saw its shares soar by an impressive 18.5% on the Hong Kong Stock Exchange. This spike occurred amid high expectations following a solid quarterly performance from the company’s cloud computing division alongside the launch of a new artificial intelligence chip. Investors are...

Continue Reading